Please enable JavaScript to continue using this application.

Compare $BMRN vs $PCVX | Chartloom

Compare

$BMRN vs $PCVX

BioMarin Pharmaceutical Inc · Vaxcyte Inc

BMRN

BioMarin Pharmaceutical Inc

PCVX

Vaxcyte Inc

Compare $BMRN vs $PCVX

Comparing BioMarin Pharmaceutical Inc and Vaxcyte Inc

BMRNBioMarin Pharmaceutical Inc

PCVXVaxcyte Inc

BMRNBioMarin Pharmaceutical Inc

Market cap

$10.59B

P/E (TTM)

146.03x

Forward P/E (NTM)

12.82x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

11.2%

YTD performance

-7.8%

52W performance

0.2%

FCF yield

6.8%

PCVXVaxcyte Inc

Market cap

$10.31B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.6%

52W performance

75.2%

FCF yield

-8.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRN

PCVX

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

PCVX

Vaxcyte Inc

Market Cap

BMRN$10.59B

PCVX$10.31B

Enterprise Value

BMRN$13.90B

PCVX$10.12B

Price

BMRN$54.80

PCVX$71.38

P/E Ratio

BMRN146.03x

PCVXN/A

P/S Ratio

BMRN3.11x

PCVX0.00x

EV/Sales

BMRN4.08x

PCVX0.00x

EV/EBITDA

BMRN16.77x

PCVX0.00x

P/B Ratio

BMRN1.75x

PCVX3.05x

P/FCF Ratio

BMRN14.61x

PCVXN/A

EV/FCF

BMRN19.17x

PCVX-10.99x

PEG Ratio

BMRN4.10x

PCVXN/A

Forward P/E (NTM)

BMRN12.82x

PCVXN/A

Forward P/S (NTM)

BMRN2.41x

PCVXN/A

Revenue (TTM)

BMRN$3.41B

PCVX$0

Revenue Growth (YoY)

BMRN11.2%

PCVXN/A

Forward Rev Growth

BMRN14.5%

PCVX157.2%

Gross Margin (TTM)

BMRN79.6%

PCVX0.0%

Operating Margin (TTM)

BMRN4.4%

PCVX0.0%

EBITDA Margin (TTM)

BMRN24.3%

PCVX0.0%

Net Margin (TTM)

BMRN2.1%

PCVX0.0%

FCF Margin (TTM)

BMRN21.3%

PCVXN/A

Net Income (TTM)

BMRN$73M

PCVX$-1.06B

FCF (TTM)

BMRN$725M

PCVX$-921M

EPS (TTM)

BMRN$0.38

PCVX-$7.37

ROE (TTM)

BMRN1.2%

PCVX-3757.0%

ROA (TTM)

BMRN82.0%

PCVX-3362.0%

ROIC (TTM)

BMRN93.0%

PCVX-3757.0%

Cash

BMRN$874M

PCVX$183M

Debt

BMRN$4.19B

PCVX$0

Net Cash/Debt

BMRN$-3.31B

PCVX$183M

Current Ratio (TTM)

BMRN2.39x

PCVX5.72x

Quick Ratio (TTM)

BMRN1.16x

PCVX5.48x

Debt/Equity (TTM)

BMRN0.66x

PCVX0.00x

Debt/Assets (TTM)

BMRN0.0%

PCVX0.0%

Interest Coverage (TTM)

BMRNN/A

PCVXN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

PCVX0.00x

Beta

BMRN0.23

PCVX1.31

52W Performance

BMRN0.2%

PCVX75.2%

YTD Performance

BMRN-7.8%

PCVX53.6%

% from 52W High

BMRN-22.8%

PCVX-21.3%

% from 52W Low

BMRN11.2%

PCVX79.0%

Asset Turnover (TTM)

BMRN0.38x

PCVX0.00x

FCF Yield (TTM)

BMRN6.8%

PCVX-8.9%

Earnings Yield (TTM)

BMRN0.7%

PCVX-10.3%

Dividend Yield (TTM)

BMRNN/A

PCVXN/A

Rule of 40

BMRN32.5

PCVX0.0

EV/GP/RG

BMRN0.18

PCVXN/A

Ticker research

View BMRN research View PCVX research

Metric	BMRN BioMarin Pharmaceutical Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$10.59B	$10.31B
Enterprise Value	$13.90B	$10.12B
Price	$54.80	$71.38
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	0.00x
EV/Sales	4.08x	0.00x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	3.05x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-10.99x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	N/A
Revenue & Growth
Revenue (TTM)	$3.41B	$0
Revenue Growth (YoY)	11.2%	N/A
Forward Rev Growth	14.5%	157.2%
Profitability
Gross Margin (TTM)	79.6%	0.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	0.0%
Net Margin (TTM)	2.1%	0.0%
FCF Margin (TTM)	21.3%	N/A
Net Income (TTM)	$73M	$-1.06B
FCF (TTM)	$725M	$-921M
EPS (TTM)	$0.38	-$7.37
ROE (TTM)	1.2%	-3757.0%
ROA (TTM)	82.0%	-3362.0%
ROIC (TTM)	93.0%	-3757.0%
Financial Health
Cash	$874M	$183M
Debt	$4.19B	$0
Net Cash/Debt	$-3.31B	$183M
Current Ratio (TTM)	2.39x	5.72x
Quick Ratio (TTM)	1.16x	5.48x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.31
52W Performance	0.2%	75.2%
YTD Performance	-7.8%	53.6%
% from 52W High	-22.8%	-21.3%
% from 52W Low	11.2%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	6.8%	-8.9%
Earnings Yield (TTM)	0.7%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	0.0
EV/GP/RG	0.18	N/A
Ticker research	View BMRN research	View PCVX research

Valuation

P/E Ratio

BMRN

146.03x

P/S Ratio

PCVX

0.00x

BMRN

3.11x

EV/FCF

PCVX

-10.99x

BMRN

19.17x

Growth & revenue

Revenue Growth TTM

BMRN

11.2%

Forward Revenue Growth

PCVX

157.2%

BMRN

14.5%

Profitability & performance

Gross Margin

BMRN

79.6%

PCVX

0.0%

ROE

BMRN

1.2%

PCVX

-3757.0%

FCF Yield %

BMRN

6.8%

PCVX

-8.9%

52-Week Performance

PCVX

75.2%

BMRN

0.2%

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

PCVX

Vaxcyte Inc

Market Cap

BMRN$10.59B

PCVX$10.31B

Enterprise Value

BMRN$13.90B

PCVX$10.12B

Price

BMRN$54.80

PCVX$71.38

P/E Ratio

BMRN146.03x

PCVXN/A

P/S Ratio

BMRN3.11x

PCVX0.00x

EV/Sales

BMRN4.08x

PCVX0.00x

EV/EBITDA

BMRN16.77x

PCVX0.00x

P/B Ratio

BMRN1.75x

PCVX3.05x

P/FCF Ratio

BMRN14.61x

PCVXN/A

EV/FCF

BMRN19.17x

PCVX-10.99x

PEG Ratio

BMRN4.10x

PCVXN/A

Forward P/E (NTM)

BMRN12.82x

PCVXN/A

Forward P/S (NTM)

BMRN2.41x

PCVXN/A

Revenue (TTM)

BMRN$3.41B

PCVX$0

Revenue Growth (YoY)

BMRN11.2%

PCVXN/A

Forward Rev Growth

BMRN14.5%

PCVX157.2%

Gross Margin (TTM)

BMRN79.6%

PCVX0.0%

Operating Margin (TTM)

BMRN4.4%

PCVX0.0%

EBITDA Margin (TTM)

BMRN24.3%

PCVX0.0%

Net Margin (TTM)

BMRN2.1%

PCVX0.0%

FCF Margin (TTM)

BMRN21.3%

PCVXN/A

Net Income (TTM)

BMRN$73M

PCVX$-1.06B

FCF (TTM)

BMRN$725M

PCVX$-921M

EPS (TTM)

BMRN$0.38

PCVX-$7.37

ROE (TTM)

BMRN1.2%

PCVX-3757.0%

ROA (TTM)

BMRN82.0%

PCVX-3362.0%

ROIC (TTM)

BMRN93.0%

PCVX-3757.0%

Cash

BMRN$874M

PCVX$183M

Debt

BMRN$4.19B

PCVX$0

Net Cash/Debt

BMRN$-3.31B

PCVX$183M

Current Ratio (TTM)

BMRN2.39x

PCVX5.72x

Quick Ratio (TTM)

BMRN1.16x

PCVX5.48x

Debt/Equity (TTM)

BMRN0.66x

PCVX0.00x

Debt/Assets (TTM)

BMRN0.0%

PCVX0.0%

Interest Coverage (TTM)

BMRNN/A

PCVXN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

PCVX0.00x

Beta

BMRN0.23

PCVX1.31

52W Performance

BMRN0.2%

PCVX75.2%

YTD Performance

BMRN-7.8%

PCVX53.6%

% from 52W High

BMRN-22.8%

PCVX-21.3%

% from 52W Low

BMRN11.2%

PCVX79.0%

Asset Turnover (TTM)

BMRN0.38x

PCVX0.00x

FCF Yield (TTM)

BMRN6.8%

PCVX-8.9%

Earnings Yield (TTM)

BMRN0.7%

PCVX-10.3%

Dividend Yield (TTM)

BMRNN/A

PCVXN/A

Rule of 40

BMRN32.5

PCVX0.0

EV/GP/RG

BMRN0.18

PCVXN/A

Ticker research

View BMRN research View PCVX research

Metric	BMRN BioMarin Pharmaceutical Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$10.59B	$10.31B
Enterprise Value	$13.90B	$10.12B
Price	$54.80	$71.38
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	0.00x
EV/Sales	4.08x	0.00x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	3.05x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-10.99x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	N/A
Revenue & Growth
Revenue (TTM)	$3.41B	$0
Revenue Growth (YoY)	11.2%	N/A
Forward Rev Growth	14.5%	157.2%
Profitability
Gross Margin (TTM)	79.6%	0.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	0.0%
Net Margin (TTM)	2.1%	0.0%
FCF Margin (TTM)	21.3%	N/A
Net Income (TTM)	$73M	$-1.06B
FCF (TTM)	$725M	$-921M
EPS (TTM)	$0.38	-$7.37
ROE (TTM)	1.2%	-3757.0%
ROA (TTM)	82.0%	-3362.0%
ROIC (TTM)	93.0%	-3757.0%
Financial Health
Cash	$874M	$183M
Debt	$4.19B	$0
Net Cash/Debt	$-3.31B	$183M
Current Ratio (TTM)	2.39x	5.72x
Quick Ratio (TTM)	1.16x	5.48x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	1.31
52W Performance	0.2%	75.2%
YTD Performance	-7.8%	53.6%
% from 52W High	-22.8%	-21.3%
% from 52W Low	11.2%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	6.8%	-8.9%
Earnings Yield (TTM)	0.7%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	0.0
EV/GP/RG	0.18	N/A
Ticker research	View BMRN research	View PCVX research